This was a smaller study than I would like, but it reversed their epigenetic aging by three years because again, it's a hormone
What effects might exenatide have on non-motor symptoms in Parkinsons disease: a post hoc analysis
Ruvolo P, Ma H, Ruvolo V, Mu H, Shober W, Yasuhiro T, Yoshizawa T, Gallardo M, Zhang X, Khoury JD, Cortex JE, Andreeff M , Post SM
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
There is no established direct pharmacological link between GLP-1/GIP medicines and B12 deficiency